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Abstract
Activation of many multi-domain signaling proteins requires rearrangement of autoinhibitory 
interdomain interactions that occlude activator binding sites. In one model for activation, the 
major inactive conformation exists in equilibrium with activated-like conformations that can be 
stabilized by ligand binding or post-translational modifications. The molecular basis for this model 
is established for the archetypal signaling adapter protein Crk-II by measuring the 
thermodynamics and kinetics of the equilibrium between autoinhibited and activated-like states 
using fluorescence and NMR spectroscopies, together with segmental isotopic labeling via 
expressed protein ligation. The results demonstrate that intramolecular domain-domain 
interactions both stabilize the autoinhibited state and induce the activated-like conformation. A 
combination of favorable interdomain interactions and unfavorable intradomain structural changes 
fine-tunes the population of the activated-like conformation and allows facile response to 
activators. This mechanism suggests a general strategy for optimization of autoinhibitory 
interactions of multi-domain proteins.
Many autoinhibited signaling proteins are responsive to small changes in the populations of 
cognate binding partners1–5. The dynamic equilibrium between autoinhibited and activated-
like conformations of signaling proteins in the absence of activators is believed to play a key 
role in achieving the seemingly contradictory tasks of preventing uncontrolled activation and 
enabling prompt response to cellular stimuli6,7. This model implies that the interdomain 
interface responsible for autoinhibition must be sufficiently stable to prevent constitutive 
activation, but sufficiently labile to allow facile kinetic exchange between autoinhibited and 
activation-competent states.
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The conformation of a protein in complex with a target molecule must, in the absence of the 
target, have a free energy equal to or greater than that of the experimentally observed apo 
structure. Consequently, the binding affinity for the target must be sufficient to overcome 
the energetic penalty associated with forming higher energy holo conformations8. The 
thermodynamics and kinetics of such conformational changes are critical for understanding 
the physical principles controlling binding affinity; however, detection of low populations of 
high energy states in the absence of binding partners represents a considerable experimental 
challenge.
A full description of the molecular mechanisms responsible for controlling the dynamic 
equilibrium between autoinhibited (closed) and activated-like (open) states requires 
comparison of the structures and thermodynamics of individual domains in isolation and in 
the context of full-length molecules, as well as knowledge of the kinetics of interconversion 
between the various populated conformational states. Moreover, unique spectroscopic 
probes are needed for studying the individual domains within the full-length multi-domain 
protein9,10. Consequently, complete descriptions are not yet available of the molecular basis 
for control of autoinhibition of multi-domain signaling proteins.
Archetypical signaling adaptor proteins of the Crk family are comprised of Src homology 2 
(SH2) and 3 (SH3) domains and have been implicated in many cellular processes including 
cell motility, proliferation and adhesion11–14 (Fig. 1a). Crk proteins mediate diverse protein-
protein interactions, through their SH2 and SH3 domains, in downstream transduction of 
growth and differentiation signals11. Crk-II consists of an N-terminal SH2 domain and two 
SH3 domains (SH2-nSH3-cSH3). The binding of the N-terminal SH3 (nSH3) domain to 
C3G, a guanine-nucleotide exchange factor for small molecular weight GTPase15, Abl16 and 
DOCK18017 contributes to the integrin signaling18 and the regulation of fibroblast 
migration11. The biological activity of the nSH3 domain of Crk-II is negatively regulated by 
the C-terminal SH3 (cSH3) domain via intramolecular domain-domain interactions11,19. The 
solution structure of Crk-II shows that the cSH3 domain stabilizes a closed autoinhibited 
state of Crk-II in which the ligand binding site of the nSH3 domain is blocked by 
interdomain interactions with the SH2 domain; however, the active site of the nSH3 domain 
is not directly occluded by the cSH3 domain19 (Fig. 1b). Alternative splicing of the c-crk 
gene yields Crk-I (SH2-nSH3), which lacks the C-terminal SH3 domain and is constitutively 
active, causing transformation of hematopoietic and fibroblast cells12,20. The NMR solution 
structure of Crk-I indicates that the active site of the nSH3 domain is exposed to solvent19, 
consistent with the inability of the SH2 domain alone to exert autoinhibitory control of 
nSH3 activity9. Various models have been proposed for control of autoinhibition of Crk-
II19,21,22; however, a complete biophysical analysis of this process, which necessarily 
involves analysis of the full-length protein and individual domains, has not been reported. 
Herein, we present a thermodynamic, kinetic and structural analysis that reveals a critical 
role for selective domain destabilization in tuning the responsiveness of Crk-II to activation.
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Results
Thermodynamics and kinetics of a dynamic equilibrium of Crk-II
Crk-II exists as an equilibrium mixture of the autoinhibited state and the open state, in which 
the binding site of the nSH3 domain is exposed to solvent (Fig. 1c). Target proteins can bind 
to the nSH3 domain of Crk-II only when the protein adopts an open state. The free energy of 
the closed autoinhibited state relative to the open activated-like state of Crk-II was 
determined from the binding affinity of a C3G-derived23 ligand to the nSH3 domain in Crk-
II and Crk-I. The binding affinity (Kint) of the ligand to the nSH3 domain in the open state 
was estimated using Crk-I (Methods). The free energy difference, ΔG° = G°open − G°closed 
= 1.5 ± 0.1 kcal mol−1, corresponds to closed and open state populations of pclosed = 92.6% 
and popen = 7.4%, respectively, for Crk-II (Table 1 and Supplementary Fig. 1).
The kinetics of ligand binding to the nSH3 domain in the context of full-length Crk-II were 
estimated from an NMR-detected titration experiment using uniformly 15N-labeled Crk-II 
and fluorescein-labeled C3G-derived ligand. Two 15N resonances in the nSH3 domain, 
W169 (ΔωN = ωbound − ωfree = 790 s−1) and A172 (ΔωN = 165 s−1), undergo slow and fast 
chemical exchange, respectively, relative to the NMR chemical shift timescale, upon 
addition of ligand (Fig. 1d). Therefore, the chemical exchange rate constant is 165 s−1 < kex 
< 790 s−1, corresponding to a bimolecular on-rate constant of 5.8 × 109 M−1 s−1 < kon < 2.8 
× 1010 M−1 s−1 for ligand binding to the nSH3 domain in the open state of Crk-II. The 
observed KD is 1.9 orders of magnitude lower for fluorescein-labeled C3G ligand than for 
the unlabeled ligand24. Assuming that koff is unaffected by the presence of the label, 6.5 × 
107 M−1 s−1 < kon < 3.1 × 108 M−1 s−1 for an unlabeled ligand is estimated (Methods). 
These results are in excellent agreement with measured on-rates for ligand binding to 
isolated SH3 domains25 and thus support use of Crk-I to estimate the intrinsic ligand binding 
affinity, Kint, for the open state of full-length Crk-II (Fig. 1c and Table 1).
Collectively, these results demonstrate that regulation of the interconversion between the 
open and closed autoinhibited conformations plays a central role in controlling Crk-II 
function. These data also show that the stability of the interface with the cSH3 domain limits 
the activation rate of Crk-II, because autoinhibition must be relieved to populate the open 
state.
Intra- and inter-domain interactions in the closed state
Considerable basal levels (~7%) of the open states of Crk-II persist, even though a large 
solvent accessible surface area (~1360 Å2) is buried between the cSH3 and other domains in 
the structure of autoinhibited Crk-II (Fig. 1a). We quantified the energetics of the 
interdomain interactions by comparing the stability of the cSH3 domain in isolation and in 
full-length Crk-II. The unfolded cSH3 domain cannot bind to the other domains of Crk-II; 
consequently, unfolding and dissociation of the cSH3 domain are thermodynamically linked. 
The effect of ligand binding on global unfolding, by monitoring the change in Tm or H/D-
exchange, has been reported for other isolated SH3 domains26,27.
NMR-detected backbone amide H/D-exchange experiments are routinely used to measure 
the unfolding free energy of small to intermediate sized proteins (<25 kDa); however, peak 
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overlap makes the application of the H/D-exchange experiment difficult for large (>30 kDa) 
proteins. We used expressed protein ligation (EPL)28 to produce segmentally labeled full-
length Crk-II, in which only the cSH3 domain is labeled with 15N (SH214N-nSH314N-
cSH315N) (Fig. 2a). Owing to the simplified NMR spectrum, all of the expected 1H-15N 
resonances in the cSH3 domain are detected in segmentally labeled full-length Crk-II (~34 
kDa) (Fig. 2b and Supplementary Fig. 2).
H/D-exchange rates were measured at 290 K for 20 residues (Fig. 2c), located in and around 
the hydrophobic core of the cSH3 domain (Fig. 2d). Strikingly, the protection factors are 
nearly equal or larger in the isolated cSH3 domain (average ΔGex = 5.58 ± 0.52 kcal mol−1) 
relative to the values measured for the cSH3 domain within full-length Crk-II (average ΔGex 
= 5.29 ± 0.41 kcal mol−1) (Fig. 2c). 1H and 15N chemical shifts (Fig. 3a and 3b) and 15N 
transverse relaxation rate measurements (Fig. 3c) demonstrate that the similarity in the 
protection factors of the cSH3 domain in isolation and in the full-length Crk-II are not due to 
dissociation of the cSH3 domain from the other domains in Crk-II. These results indicate 
that the cSH3 domain does not experience any net favorable interdomain binding free 
energy, even though a large surface area is buried in the autoinhibited state.
We characterized the conformational properties of the linker region between the nSH3 and 
cSH3 domains, residues 224–237, in full-length Crk-II. Heteronuclear {1H}-15N NOE 
values are < 0.6 for residues in the linker, compared with values >0.6 for residues in 
elements of secondary structure, in full-length Crk-II and are similar to values measured for 
the isolated cSH3 domain (Fig. 3d). We did not observe any resonance cross-peaks in the 
first NMR spectrum in H/D exchange experiments for residues in the linker region in full-
length Crk-II, indicating that amide proton exchange protection factors are small. We note 
that segmentally labeled protein must be used to measure accurate NMR H/D exchange and 
spin relaxation parameters for the linker region owing to the serious spectral overlap in 
uniformly labeled Crk-II, which prevents quantitative peak intensity measurements 
(Supplementary Fig. 3). Thus, thermodynamically unfavorable interactions must occur 
simultaneously in the cSH3 domain, and not the linker, upon formation of the 
thermodynamically favorable domain-domain interface of the autoinhibited state.
Conformational change of Trp275 within the cSH3 domain
We investigated the structural changes in the cSH3 domain that may offset favorable 
interdomain interactions, and thereby allow facile activation of Crk-II. The backbone 15N 
and 1H chemical shifts of the cSH3 domain in the context of autoinhibited Crk-II and 
activated Crk-II (Crk-II/C3G) are broadly similar (Fig. 3b), indicating that modest 
conformational changes around the interdomain interface of the cSH3 domain are sufficient 
to induce the open conformation of Crk-II. The 15Nε1 resonance for the indole ring of 
Trp275 of the cSH3 domain has the largest change upon activation (Fig. 3b and 
Supplementary Fig. 2). Trp275 is highly conserved in Crk-II (Supplementary Fig. 4), and is 
critical for stabilizing the cSH3 domain and the autoinhibited state of Crk-II19,29. H/D 
exchange experiments show that side-chain indole 1Hε1 of Trp275 is well protected from 
solvent in the isolated cSH3 domain (Supplementary Fig. 5a and 5c), but not in full-length 
Crk-II (Supplementary Fig. 5b and 5d). We performed fluorescence experiments to confirm 
Cho et al. Page 4
Nat Struct Mol Biol. Author manuscript; available in PMC 2012 January 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
that Trp275 is protected from solvent exposure in the isolated cSH3 domain30,31. The Trp 
fluorescence emission maximum is blue-shifted compared with free indole (Table 2). We 
also compared the Stern-Volmer constant (Ksv) of the isolated cSH3-WT domain to free 
indole (Table 2). The fluorescence results show that Trp275 has a single conformation in 
which the side chain is buried into the hydrophobic core. These results imply that domain-
domain interactions in full-length Crk-II perturb the hydrophobic core of the cSH3 domain 
by switching Trp275 to a more exposed conformation.
The solvent-protection of the side chain of Trp275 is consistent with solution structure of the 
isolated cSH3 domain (PDB code; 2GGR). The indole ring of Trp275 is packed against 
several hydrophobic residues, resulting in the burial of 1117 Å2 of hydrophobic surface 
area32. In contrast, Trp275 populates a different χ1 and χ2 rotamer in full-length Crk-II and 
the indole ring is flipped toward the binding interface with the SH2 domain (Fig. 4a).
Rotameric mutation of Trp275 using non-coded amino acid
We sought to design a mutant of cSH3 that would mimic the conformation of Trp275 
observed in full-length Crk-II. The energetic consequences of local conformational changes 
of a single Trp residue are difficult to evaluate using traditional mutagenesis, because 
substitutions conserving size and molecular structure cannot be made using natural amino 
acids. We selectively replaced Trp275 in the isolated cSH3 domain by the non-natural 
amino acid 7-aza Trp (7AW), in which the carbon atom in the 7-position of indole ring is 
replaced by nitrogen. This mutation does not perturb the structure of the side chain, except 
for the increased polarity of the ring. The 7-position of the Trp275 side chain is buried in the 
hydrophobic core of the isolated cSH3 and we reasoned that the side chain of 7AW would 
reorient to expose the 7-position to solvent, mimicking the effects of changing the χ1 
rotamer of Trp275 in Crk-II (Fig. 4a). Thus the 7AW substitution can be used as a 
“rotameric mutation”. The effect of 7AW on the stability of the cSH3 domain was measured 
using urea-induced denaturation. The stability of the isolated cSH3-7AW domain was 
decreased by almost ~1 kcal mol−1 relative to wild type isolated cSH3 (Table 2 and 
Supplementary Fig. 6). The m-value also decreased, indicating that the hydrophobic core is 
slightly perturbed in cSH37AW, compared to wild-type cSH3.
We performed fluorescence quenching experiments to confirm that the 7AW substitution 
perturbed the rotameric conformational state of Trp27530,31. We compared the Ksv of the 
isolated cSH3-7AW domain to free 7-azaindole, because of the difference in intrinsic 
quenching efficiencies of W and 7AW (Table 2 and Fig. 4b and 4c). The result for the 
cSH3-7AW domain shows that the protein populates major (~89%) and minor (~11%) 
conformations corresponding to the buried and exposed conformation of the side chain of 
7AW, respectively. In addition, the 1H-15N HSQC spectrum of the cSH3-7AW showed that 
several resonances from residues near 7ATrp275 are split into two peaks, further confirming 
the presence of two different conformations (data not shown). In contrast, the spectrum of 
the isolated wild type cSH3 domain showed single resonance peaks for each residue. These 
results demonstrate that the incorporation of 7AW induces the rotation of the side chain 
toward the surface of the cSH3 domain (Fig. 4a). We used these data in combination with 
the unfolding free energy of the cSH3-7AW ensemble to estimate an energetic penalty of 
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2.04 ± 0.38 kcal mol−1 for rotation of Trp275 in the autoinhibited form of Crk-II (for details 
see Supplementary Methods). The substantial energetic penalty incurred when the side chain 
of Trp275 flips out to enable favorable interdomain interactions provides an explanation for 
the absence of stabilization of the cSH3 domain in the context of full-length Crk-II.
Discussion
Quantifying the energetics of the structural changes upon domain-domain interactions is 
central to understanding signaling processes at the molecular level. We have developed a 
self-consistent thermodynamic and kinetic model for the control of the autoinhibition of 
Crk-II in which favorable domain-domain interactions are balanced by structural changes, 
including perturbations of Trp275, that reduce the stability of the cSH3 domain, in order to 
avoid over-stabilization of the autoinhibited state (Fig. 4d). The moderate conformational 
change of the side chain of Trp275 destabilizes the cSH3 domain by a surprisingly large ~2 
kcal mol−1. However, packing interactions in the hydrophobic core of SH3 domains are 
highly conserved and domain stability is very sensitive to perturbations of the hydrophobic 
core33.
The hypothetical binding energy between the cSH3 and SH2 domains of Crk-II that would 
be expected if exposure of the Trp275 side chain were not energetically unfavorable is 
important in assessing whether additional conformational changes contribute to the free 
energy difference between the closed and open states. The intramolecular binding energy 
between the two domains can be estimated using the relationship Ka,intra = Ka,inter*Ceffective, 
in which Ceffective is the effective local concentration of the binding domain and Ka,inter is 
the intermolecular binding affinity34. The intermolecular binding constant between the cSH3 
and SH2 domains of Crk-II is not known; however, the Abl SH3 domain binds to a proline-
rich peptide sequence derived from the DE-loop of the Crk-II SH2 domain with Ka,inter ~360 
µM35. A theoretical investigation of the intramolecular interaction of SH3 domains showed 
that the effective local concentration is ~ 80 mM when two domains are separated by the 
optimum linker length34. Thus, the hypothetical intramolecular binding energy, in which the 
unfavorable interaction of Trp275 is not considered, would be ~ −3.2 kcal mol−1. This result 
is consistent with our estimation of free energy difference between the closed state and open 
states in which the Trp275 side chain is buried (Fig. 4d). Thus, the offset of the favorable 
interdomain interaction (~ −3.2 kcal mol−1) by unfavorable conformational change from 
buried to exposed conformations of Trp275 (~2 kcal mol−1) reduces the free energy 
difference between the closed and open states to ~1.2 kcal mol−1. The self-consistency 
between this latter quantity and the difference measured independently (Table 1) indicates 
that the conformational change associated with Trp275 is the dominant contribution to 
tuning the free energy difference between autoinhibited and activated-like states of Crk-II. 
The intramolecular binding free energy of the cSH3 domain to other regions of Crk-II is 
relatively small, compared to other SH3-ligand interactions, perhaps because the 
intramolecular binding interface of Crk-II is not optimized for ideal binding36.
Two other models have been proposed for control of autoinhibition of Crk-II. In the first 
model, autoinhibition of chicken Crk-II is controlled by interactions between the nSH3 and 
cSH3 domain mediated via isomerization of Pro23737. However, that work made use of a 
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truncated Crk construct (nSH3-cSH3) that lacked the SH2 domain. The nSH3 and cSH3 
domains do not directly interact in the structure of the full-length human protein19. In 
addition, the amino acid sequence adjacent to Pro237 in the chicken Crk-II sequence differs 
from the corresponding human and mouse sequences (Supplementary Fig. 4). These 
differences suggest that the regulatory mechanism of chicken Crk-II may be different from 
that of human and mouse Crk-II. In the second model, the autoinhibited state of human Crk-
II is stabilized by rigidification of the linker region (residues 224–236) tethering the nSH3 
and cSH3 domains19. However, heteronuclear NOE data (Fig. 3d) indicate that the linker 
region experiences extensive conformational fluctuations on picosecond-nanosecond time 
scales. In addition, the H/D exchange data indicate that the linker region undergoes slower 
interconversion between associated (exchange non-competent) and dissociated (exchange 
competent) states with minor free energy differences.
In conclusion, intramolecular domain-domain interactions induce differential effects on the 
thermodynamic stabilities of individual domains to finely adjust the overall functional 
response of Crk-II. The interplay of these competing effects acts as the driving force to 
induce the basal level of the open (activated-like) state required for activation of Crk-II. The 
thermodynamically unfavorable conformational change of the cSH3 domain upon 
autoinhibition contributes to timely activation in response to cellular stimuli. The mode of 
regulation revealed by the present study is likely to be found in other multi-domain proteins. 
In the limiting case, order-to-disorder transitions may maximally offset favorable domain-
domain interactions38.
Methods
Protein Expression and Purification
Detailed procedures for preparation of protein samples are described in Supplementary 
Methods. Intactness of segmentally labeled Crk-II was confirmed by comparing the NMR 
chemical shifts and R2 relaxation rate constants with those of uniformly 15N labeled Crk-II 
which was prepared in conventional protein preparation method (Supplementary Fig. 7). 
Isolated cSH3 domain was confirmed to be monomeric by measuring the concentration 
dependent NMR transverse relaxation rate constants (Supplementary Fig. 7).
Ligand Binding Assays
A fluorescence-based titration assay was used to measure the affinity constants of both C3G-
ligand15 and a phosphopeptide-ligand39. All ligand binding measurements were performed 
at 25°C in a stirred 1 cm pathlength cuvette. The excitation wavelength was 295 nm. C3G-
ligand, HPPPPLPPKRRK-ε-fluorescein-G-NH2, was prepared by solid-phase peptide 
synthesis. Dissociation constants were calculated by assuming the formation of a 1:1 
complex and by fitting corrected fluorescence intensities to the equation;
(1)
Cho et al. Page 7
Nat Struct Mol Biol. Author manuscript; available in PMC 2012 January 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
where F and ΔF are the change and maximum change in protein fluorescence, respectively. 
P is the total protein concentration, L is the total ligand concentration, and KD is the 
equilibrium dissociation constant. Experiments were performed in triplicate.
The free energy difference between the open and closed states of Crk-II was calculated 
using eq (2). In our three state binding model (Fig. 1c), the equilibrium constant (KO) for the 
opening and closing process between the closed and open states of Crk-II was calculated 
from the apparent binding affinity (KD) of the C3G ligand and the binding affinity (Kint) of 
C3G ligand:
(2)
where,  and
(3)
Determination of the bimolecular rate constant, kon
The bi-molecular rate constant, kon, was determined from the exchange rate constant, kex, 
estimated from a NMR-titration experiment. The kex for the ligand binding to the Crk-II is 
defined by the equation:
(4)
where kon and koff represent bimolecular on-rate and unimolecular off-rate constants, 
respectively, between the open and ligand-bound states (Fig. 1c), [L] represents the free 
ligand concentration, and Kint represents the dissociation constant of C3G-ligand to Crk-I. 
The reported kon was calculated with KO of 0.074 (popen = 7.4% in Crk-II) and [L]free = 
0.077 µM (protein:ligand = 1:0.22). The NMR titration experiment (Fig. 3c) showed that the 
exchange rate is 165s−1 < kex < 790 s−1 at this protein:ligand ratio resulting in 5.8 × 109 M−1 
s−1 < kon < 2.8 × 1010 M−1 s−1. The observed KD for fluorescein-labeled C3G-ligand is 85-
fold lower than fluorescein-free C3G-ligand24. Despite this effect of fluorescein, the label is 
necessary to quantify the concentration of ligand in solution because the ligand sequence 
lacks spectroscopic probes and measurements of peptide concentrations using amino acid 
analysis have large errors. Thus, the observed kon rate was corrected by the ratio of KD for 
label-free and fluorescein-labeled ligand. The correction yields estimates of 6.5 × 107 M−1 
s−1 < kon < 3.1 × 108 M−1 s−1.
NMR spectroscopy
A Bruker DRX600 NMR spectrometer equipped with a CryoProbe was used. Chemical 
shifts for different protein states and complexes were measured in a buffer containing 10 
mM sodium phosphate (pH 7.0), 100 mM NaCl, 2 mM DTT at 298 K. Chemical shift 
changes were calculated as:
(5)
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The 1H-15N NOE spectra were collected for segmentally labeled Crk-II (SH214N-nSH314N-
cSH315N) and for the isolated cSH3 domain with and without 1H saturation for 4.0 s at 600 
MHz equipped with a CryoProbe. Recycle delays for NOE experiment and control 
experiments were 3.0 s and 9.0 s, respectively. The delay between NOE and control 
experiments was 18.0 s. 1H-15N HSQC, 3D-HNCO, HNCACB, CBCA(CO)NH, and 
HN(CA)CO experiments were used for backbone assignment.
Equilibrium Unfolding Measurements
Urea-denaturation experiments were performed at 298 K by monitoring the change in 
fluorescence signal intensity recorded at 340 nm and 398 nm for wild type cSH3 and 
cSH3-7AW, respectively. Details of experimental conditions are described in 
Supplementary Methods.
H/D Exchange Rate Measurements
H/D exchange experiments were performed at 290 K on a Bruker DRX 600 MHz NMR 
spectrometer equipped with a CryoProbe. Samples for H/D exchange experiments were 
exchanged into a buffer containing 10 mM sodium phosphate (pD 6.6), 200 mM NaCl, 2 
mM DTT (d11) in 100% D2O, using Micro Bio-spin columns (BIO-RAD). H/D-exchange 
rates were determined from peak intensity changes in a series of 1H-15N HSQC experiments. 
Reported exchange rates are the average of two or three repeated experiments. Exchange 
rates for residues whose exchange was dominated by local conformational fluctuations could 
not be determined, because the intrinsic rate of exchange is too high at the experimental pH 
(pD = 6.6). The folding rate for the cSH3 domain has previously been measured to be 82.6 ± 
2.9 s−1,32; thus the system is within the EX2 regime.
Fluorescence Quenching Experiments
Steady state quenching experiments were performed at 298K. Samples were prepared in a 
buffer containing 20mM Na-phosphate (pH 7.2), 100mM NaCl, 3mM TCEP. The 
concentration of each sample was adjusted to ensure that the OD was 0.1 or less at the 
excitation wavelength to prevent inner filter effects. Acrylamide was used as a quencher. 
Observed signal intensity was corrected for both dilution effects and for the inner filter 
effect upon adding acrylamide using OD295nm = 0.23 M−1 cm−1. The excitation wavelengths 
for cSH3-WT (and free indole) and cSH3-7AW (and 7-azaindole) were 295 nm and 310 nm, 
respectively. Quenching data for homogenously emitting samples (free indole, 7-azaindole 
and cSH3-WT) were analyzed using the Stern-Volmer equation30:
(6)
For cSH3-7AW, the Stern-Volmer equation was re-written to take into account 
heterogeneous fluorescent components31:
(7)
where F0 and F represent fluorescence intensity in the absence and presence of quencher, Q, 
respectively. Ksv,1 and f1 is the Stern-Volmer constant and population fraction of the 
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exposed conformation and Ksv,2 is the Stern-Volmer constant of the buried conformation. V 
represents the sphere of action. Application of equation 7 to the quenching data of the cSH3-
WT domain yielded unrealistic fitting, indicating that equation 6 is adequate for fitting the 
data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Scheme for the autoinhibition and activation of Crk-II
(a) Solution structure of Crk-II (SH2; blue, nSH3; yellow, cSH3; green) (pdb id; 2EYZ19). 
Active site residues of each domain are shown in stick-and-ball format. (b) Expanded view 
of the interface between the active site of the nSH3 and SH2 domain in Crk-II. Active site 
residues are shown in red on the surface representation of the nSH3 domain. Interface 
residues of SH2 domain are shown in stick format. (c) Schematic representation of a three-
state equilibrium of ligand binding to the nSH3 domain in Crk-II (SH2; blue, nSH3; yellow, 
cSH3; green, ligand; red). KO is the equilibrium constant between the closed and open state, 
and Kint is the intrinsic binding affinity of the ligand to the nSH3 domain in the open state. 
C and O represent the closed and open state of Crk-II, respectively. L represents the ligand 
that binds to the nSH3 domain. (d) Change in the chemical shift of W169 (upper panel) and 
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A172 (lower panel) as a function of C3G-ligand concentration. The ratios of protein and 
ligand are 1:0 (red), 1:0.22 (green), 1:0.63 (cyan), 1:0.79 (black) and 1:1.19 (blue).
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Figure 2. NMR analysis of the cSH3 domain within full-length Crk-II
(a) Schematic diagram outlining preparation of segmentally labeled Crk-II (residues from 
208 to 304 are 15N-labeled). (b) Overlay of the 1H-15N HSQC spectrum of uniformly 15N-
labeled Crk-II (black) and segmentally labeled Crk-II (red). (c) NMR-detected H/D-
exchange free energy of unfolding of the cSH3 domain in isolated (black), and Crk-II (grey) 
The error bars represent standard deviation of three repeated experiments. (d) Residues 
detected in the H/D-exchange experiment are shown as spheres on the structure of the cSH3 
domain.
Cho et al. Page 14
Nat Struct Mol Biol. Author manuscript; available in PMC 2012 January 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Structural and dynamic analysis of the cSH3 domain within Crk-II
(a) Chemical shift differences (Δδ) of the cSH3 domain in Crk-II (black), and C3G-ligand 
bound Crk-II (green), relative to the isolated cSH3 domain. The inset shows the locations of 
the residues whose resonances changed markedly between isolated cSH3 and Crk-II (top 
25% in the deviation plot). (b) Chemical shift differences of the cSH3 domain in C3G-
ligand bound Crk-II, compared to those within Crk-II. The difference for the 15Nε1 
resonance of Trp275 is shown as a bar. (c) Comparison of average R2 rates of the cSH3 
domain in isolation (Mw=8,569 Da), in Crk-II, and in Crk-II/C3G (~33,830 Da). The dashed 
line represents the molecular weight dependent R2 rates calculated using isotropic rotational 
correlation times calculated from Stokes’ law. Error bars represent the standard deviation of 
average R2. (d) {1H}-15N heteronuclear NOE measurements for the cSH3 domain in 
isolation, residues 232–304, (closed circles) and within Crk-II, residues 208–304, (open 
circles). The residues corresponding to the linker region, residues 208–236, are shaded in the 
plot. Error bars represent the propagated uncertainties of two repeated experiments. The 
uncertainty was estimated using background noise of the spectrum.
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Figure 4. Conformation of Trp275 modulates the stability of the cSH3 domain
(a) Comparison of the position of the indole ring of Trp275 in the structures of isolated 
cSH3 domain (green, pdb id: 2GGR32) and full-length Crk-II (silver, pdb id: 2EYZ19). The 
7-position of the Trp residue is highlighted in red. Steady-state fluorescence quenching 
experiments for (b) free indole (closed circles) and 7-azaindole (open circles) and (c) 
isolated cSH3-WT (closed circles) and isolated cSH3-7AW (open circles). The solid lines 
represent the best fit model using the Stern-Volmer relationship (Methods). (d) Schematic 
representation of the effects of the conformational change of Trp275 on the equilibrium 
between the open and closed states of Crk-II (W represents Trp275). Reduced stability of the 
cSH3 upon interdomain interactions reduces the activation barrier between the open and 
closed states of Crk-II.
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Table 1
Binding constants of the C3G-ligand to the nSH3 domain of various states of Crk
Proteins KD (nM) 1Stability (referenced to Crk-I)
(kcal mol−1)
2Crk-I 22.5 ± 1.3 -
Crk-II 285.5 ± 19.0 1.5 ± 0.1
1Stabilities were calculated from KO (Methods)
2
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Table 2
Thermodynamic and fluorescence quenching parameters of the wild type cSH3 domain and the cSH3 domain 
which contains 7AW at position 275.
Proteins ΔG°
(kcal mol−1)
m
(kcal mol−1M−1)
Ksv
(M−1)
λmax
(nm)
cSH3-WT 3.3 ± 0.3 0.7 ± 0.1 6.7 ± 0.2 325
Indole - - 34.2 ± 1.0 340
cSH3-7AW 2.5 ± 0.4 0.5 ± 0.1 4.7 ± 1.31
0.001 ± 0.0052
373
7-azaindole - - 5.0 ± 0.1 382
1Stern -Volmer constant of exposed species deduced from the fit of the data.
2Stern -Volmer constant of buried species deduced from the fit of the data.
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